Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Bull

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2011
Improved survival in heart transplant patients living at high altitudeCurtis J Wozniak, Bradley C Baird, Josef Stehlik, et al.
Pulmonary Circulation|June 3, 2016
Pulmonary arterial hypertension in primary amyloidosisMeghan M Cirulis, Lyska L Emerson, David A Bull, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2003
Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarctionDavid A Bull, Stephen H Bailey, Jeffrey J Rentz, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 3, 2022
Outcomes of Venovenous Extracorporeal Membrane Oxygenation in Viral Acute Respiratory Distress SyndromeToshinobu Kazui, Chiu-Hsieh Hsu, Scott D Lick, et al.
Journal of Translational Medicine|June 19, 2015
Novel xeno-free human heart matrix-derived three-dimensional scaffoldsDolly Holt-Casper, Jeff M Theisen, Alonso P Moreno, et al.
Biomaterials|October 26, 2010
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardiumArlo N McGinn, Hye Yeong Nam, Mei Ou, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF deliveryLane V Christensen, Chien-Wen Chang, James W Yockman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 12, 2006
Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapyMinhyung Lee, Donghoon Choi, Min Ji Choi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2008
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarctionJames W Yockman, Andrew Kastenmeier, Harold M Erickson, et al.
Circulation Research|August 22, 2014
Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathyTimothy D Henry, Jay H Traverse, Baron L Hammon, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2011
Improved survival in heart transplant patients living at high altitudeCurtis J Wozniak, Bradley C Baird, Josef Stehlik, et al.
Pulmonary Circulation|June 3, 2016
Pulmonary arterial hypertension in primary amyloidosisMeghan M Cirulis, Lyska L Emerson, David A Bull, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2003
Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarctionDavid A Bull, Stephen H Bailey, Jeffrey J Rentz, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 3, 2022
Outcomes of Venovenous Extracorporeal Membrane Oxygenation in Viral Acute Respiratory Distress SyndromeToshinobu Kazui, Chiu-Hsieh Hsu, Scott D Lick, et al.
Journal of Translational Medicine|June 19, 2015
Novel xeno-free human heart matrix-derived three-dimensional scaffoldsDolly Holt-Casper, Jeff M Theisen, Alonso P Moreno, et al.
Biomaterials|October 26, 2010
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardiumArlo N McGinn, Hye Yeong Nam, Mei Ou, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF deliveryLane V Christensen, Chien-Wen Chang, James W Yockman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 12, 2006
Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapyMinhyung Lee, Donghoon Choi, Min Ji Choi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2008
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarctionJames W Yockman, Andrew Kastenmeier, Harold M Erickson, et al.
Circulation Research|August 22, 2014
Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathyTimothy D Henry, Jay H Traverse, Baron L Hammon, et al.
Pageof 9